policy+practice

The Blue Cross Blue Shield Association and others say they have agreed to invest in a nonprofit’s effort to develop and sell cheaper drugs.

How Germany sets drug prices and identifying lessons for the United States.

No bill was too small to get PhRMA’s attention.

The intergovernmental regional initiatives of collaboration around access to medicines policy are here to stay.

THE UK Government has sought to reassure MSPs that medicine prices will not be affected as part of any future UK-US trade deal after Brexit.

State and federal spending on prescription drugs is dramatically outpacing inflation, even after accounting for rebates, according to a new analysis of federal data.

UK's NICE has rejected a number of drugs from coverage recently based on cost-effectiveness criteria.

State health leaders trying to reduce the number of people dying from overdoses.

A proposal to import prescription drugs from Canada to New Hampshire attracted bipartisan support at the Statehouse.

Suit didn’t show McKesson participated in price fixing, judge says.

A generic version of Copaxone, one of the most popular drugs to treat multiple sclerosis, didn't do much to lower costs for patients.

Well here’s what happened when Germany ignored those warnings.

About 3,400 pharmacies in Lebanon are suffering from the drop in prices of pharmaceutical drugs, facing the risk of shutting down in the years to come if they can't secure enough revenues.

Hit hard by the opioid crisis, West Virginia is now also contending with a child welfare crisis.

A Republican Federal Trade Commissioner said Medicare should have more power to negotiate drug costs.